American ginseng suppresses inflammation and DNA damage associated with mouse colitis

Carcinogenesis

Volumn 29, Issue 12, 2008, Pages 2351-2359

  Jin, Yu ^a   Kotakadi, Venkata S ^a   Ying, Lei ^a   Hofseth, Anne B ^a   Cui, Xiangli ^a   Wood, Patricia A ^b   Windust, Anthony ^c   Matesic, Lydia E ^b   Pena, Edsel A ^b   Chiuzan, Codruta ^b   Singh, Narendra P ^b   Nagarkatti, Mitzi ^b   Nagarkatti, Prakash S ^b   Wargovich, Michael J ^d   Hofseth, Lorne J ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CYCLOOXYGENASE 2; DEXTRAN SULFATE; GINSENG EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; OXAZOLONE; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIMARY PREVENTION; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; COMET ASSAY; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DNA DAMAGE; FLUORESCENT ANTIBODY TECHNIQUE; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; RESPIRATORY BURST; TUMOR SUPPRESSOR PROTEIN P53;

EID: 57349157683     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn211     Document Type: Article

References (35)

1. Itzkowitz,S.H. et al. (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 287 G7-G17.
2. Hilsden,R.J. et al. (2003) Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: Results from a national survey. Am. J. Gastroenterol., 98, 1563-1568.
3. Head,K. et al. (2004) Inflammatory bowel disease. Part II: Crohn's disease - pathophysiology and conventional and alternative treatment options. Altern. Med. Rev., 9, 360-401.
4. Hofseth,L.J. (2006) Ginseng and cancer. Healthy Aging, 53-58.
5. Hofseth,L.J. et al. (2007) Inflammation, cancer, and targets of ginseng. J. Nutr., 137, 183S-185S.
6. Hofseth,L.J. et al. (2003) Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl Acad. Sci. USA 100, 143-148.
7. Seril,D.N. et al. (2002) Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig. Dis. Sci., 47, 1266-1278.
8. Vuksan,V. et al. (2000) American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch. Intern. Med., 160, 1009-1013.
9. Vuksan,V. et al. (2001) American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. Am. J. Clin. Nutr., 73, 753-758.
10. Stavro,P.M. et al. (2006) Long-term intake of North American ginseng has no effect on 24-hour blood pressure and renal function. Hypertension, 47, 791-796.
11. Reagan-Shaw,S. et al. (2007) Dose translation from animal to human studies revisited. FASEB J., 17, 17.
12. Wirtz,S. et al. (2007) Chemically induced mouse models of intestinal inflammation. Nat. Protoc., 2, 541-546.
13. Kotakadi,V. et al. (2008) Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis, 28, 1799-1806.
14. Ying,L. et al. (2005) Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res., 65, 9132-9136.
15. Olive,P.L. et al. (1990) Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the 'comet' assay. Radiat. Res., 122, 86-94.
16. Neuman,M.G. (2007) Immune dysfunction in inflammatory bowel disease. Transl. Res., 149, 173-186.
17. Sartor,R.B. (2006) Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol., 3, 390-407.
18. Hofseth,L.J. et al. (2006) Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochim. Biophys. Acta, 1765, 74-84.
19. Kawada,M. et al. (2007) Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J. Gastroenterol., 13, 5581-5593.
20. Strober,W. et al. (2002) The immunology of mucosal models of inflammation. Annu. Rev. Immunol., 20, 495-549.
21. Luhrs,H. et al. (2002) Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand. J. Gastroenterol., 37, 458-466.
22. Baumgart,D.C. et al. (2007) Inflammatory bowel disease: Cause and immunobiology. Lancet, 369, 1627-1640.
23. Targan,S.R. (2006) Current limitations of IBD treatment: Where do we go from here? Ann. N. Y. Acad. Sci., 1072, 1-8.
24. Vuksan,V. et al. (2000) American ginseng improves glycemia in individuals with normal glucose tolerance: Effect of dose and time escalation. J. Am. Coll. Nutr., 19, 738-744.
25. Hsu,C.C. et al. (2005) American ginseng supplementation attenuates creatine kinase level induced by submaximal exercise in human beings. World J. Gastroenterol., 11, 5327-5331.
26. Stavro,P.M. et al. (2005) North American ginseng exerts a neutral effect on blood pressure in individuals with hypertension. Hypertension, 46, 406-411.
27. Yuan,C.S. et al. (2004) Brief communication: American ginseng reduces warfarin's effect in healthy patients: A randomized, controlled trial. Ann. Intern. Med., 141, 23-27.
28. Nam,S.Y. et al. (2008) DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. Exp. Biol. Med. (Maywood), 233 180-191.
29. Park,S. et al. (2005) Rescue of Helicobacter pylori-induced cytotoxicity by red ginseng. Dig. Dis. Sci., 50, 1218-1227.
30. Ivanova,T. et al. (2006) Antimutagenic effect of polysaccharide ginsan extracted from Panax ginseng. Food Chem. Toxicol., 44 517-521.
31. Panwar,M. et al. (2005) Inhibition of benzo(a)pyrene induced lung adenoma by Panax ginseng extract, EFLA400, in Swiss albino mice. Biol. Pharm. Bull., 28, 2063-2067.
32. Rhee,Y.H. et al. (1991) Inhibition of mutagenesis and transformation by root extracts of Panax ginseng in vitro. Planta Med., 57, 125-128.
33. Fuss,I.J. et al. (1999) Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology, 117, 1078-1088.
34. Rivera,E. et al. (2005) The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine, 23, 5411-5419.
35. Predy,G.N. et al. (2005) Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: A randomized controlled trial. CMAJ, 173, 1043-1048.